The purpose of this study was to prepare eight sub-fractions from leaves and flowers of Erica arborea L., characterize their phytochemicals constituents and investigate their potential antioxidant, in order to validate the beneficial medicinal properties of this shrub in Algeria folk medicine. Total polyphenols, flavonoids and condensed tannins contents were determined using Folin-Ciocalteu’s, aluminum chloride and vanillin reagents, respectively. The in vitro antioxidant activity was evaluated by using 2,2-diphenyl-l-picrylhydrazyl and reducing power assay. E. arborea L. contains various compounds such as polyphenols, flavonoids, tannins, quinones, anthraquinones, saponins and terpenoids in different sub-fractions. All the tested extracts showed an appreciable total phenolic, flavonoids and condensed tannins contents as well as strong antioxidant capacity. The highest total phenolic and flavonoids content was found in the ethyl acetate extracts ranging from 649.38 to 944.55 mg gallic acid equivalent/g dry extract and 65.31 to 67.15 mg quercetin equivalent/g dry extract, respectively. Whereas, the highest condensed tannins content was found in the crude extract for leaves and aqueous extracts for flowers. The ethyl acetate extract of the flowers and the crude extract of leaves exhibited the better antioxidant activity by DPPH assay (IC50 =17.72 µg/mL) and reducing power assays (IC50 = 2.91 µg/mL), respectively. Our findings indicate that leaves and flowers extracts are rich in natural antioxidant substances and have good qualities in antioxidant properties and may be beneficial against diver’s disorders related to free radicals.
4 April 2025 in Revista Científica de la Facultad de Ciencias Veterinarias
Origanum majorana L. (Lamiaceae) has been prescribed in folk medicine for therapeutic purposes such as cancer, asthma, dizziness, rheumatism and inflammatory diseases. To evaluate for the first time the decoction (DecE) and hydro–ethanolic (HEE) extracts of the aerial part of O. majorana. The phytochemical analysis (LC–MS/MS), antioxidant, anti–inflammatory and analgesic potentials were analysed. LC–MS/MS analysis identified 17 components in the extracts. The main compounds detected in the aerial parts of O. majorana include rosmarinic acid (≥ 50%), elagic acid (≥ 20%), indomethacin along with flavonoids, phenolics, benzopyrone, hydroquinones, indolyl acetic acid. Both extracts showed potent antioxidant effects in various antioxidant assay models. Through the eggs protein denaturation assay, both plant extracts showed high in vitro anti–inflammatory effect of the order of 86.91±0.00% for DecE and 85.04±0.00 % for HEE (1.4 mg·mL-1). Acute toxicity measurement revealed no mortality or behavioral changes during the testing period, confirming the two extracts not toxic with an LD50 > 2 g·kg-1. The in vivo anti–inflammatory effects were found to be statistically significant (P<0.05), reducing the edematous response by 78.40 ± 2.52 % and 77.36 ± 3.88 % in DecE and HEE, respectively. Additionally, at a dose of 400.0 mg·kg-1, both extracts exhibited significant analgesics activity (P<0.05) against acetic acid induced abdominal constriction in mice, with inhibition rates of 78.54 ± 3.30% for DecE and 66.99 ± 1.34% for HEE. The results indicate aerial part extracts of O. majorana have potent anti–inflammatory effects and may prove to have potential health benefits.